|
US2403608A
(en)
|
1940-12-19 |
1946-07-09 |
Socony Vacuum Oil Co Inc |
Method of coking oils
|
|
US2609508A
(en)
|
1943-04-24 |
1952-09-02 |
Bell Telephone Labor Inc |
Wave generating circuits
|
|
US2489708A
(en)
|
1945-01-12 |
1949-11-29 |
United Metal Box Co Inc |
Shelf support combination and cabinet
|
|
US2501008A
(en)
|
1948-08-23 |
1950-03-21 |
John G Schramm |
Safety knob
|
|
CH482813A
(de)
|
1967-06-16 |
1969-12-15 |
Ciba Geigy |
Flockulationsbeständige Pigmentpräparate und Verfahren zu deren Herstellung
|
|
US3613808A
(en)
|
1968-12-18 |
1971-10-19 |
Fmc Corp |
Article-sorting apparatus with transfer-error-reducing arrangement
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US4472509A
(en)
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
JPS5938877A
(ja)
|
1982-08-30 |
1984-03-02 |
Musashi Eng Kk |
紙葉判別方法
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4599230A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4608251A
(en)
|
1984-11-09 |
1986-08-26 |
Pitman-Moore, Inc. |
LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
|
|
US4601903A
(en)
|
1985-05-01 |
1986-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
|
|
US4938948A
(en)
|
1985-10-07 |
1990-07-03 |
Cetus Corporation |
Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
EP0281604B1
(en)
|
1986-09-02 |
1993-03-31 |
Enzon Labs Inc. |
Single polypeptide chain binding molecules
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5750172A
(en)
|
1987-06-23 |
1998-05-12 |
Pharming B.V. |
Transgenic non human mammal milk
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5055303A
(en)
|
1989-01-31 |
1991-10-08 |
Kv Pharmaceutical Company |
Solid controlled release bioadherent emulsions
|
|
US5271961A
(en)
|
1989-11-06 |
1993-12-21 |
Alkermes Controlled Therapeutics, Inc. |
Method for producing protein microspheres
|
|
US5188837A
(en)
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
JPH049249A
(ja)
|
1990-04-27 |
1992-01-14 |
Kusuda:Kk |
塗型剤吹き付け機
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
FR2670787B1
(fr)
|
1990-12-18 |
1995-06-23 |
Pasteur Institut |
Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
|
|
US5871746A
(en)
|
1990-12-18 |
1999-02-16 |
Institut National De La Sainte Et De La Recherche Medicale (Inserm) |
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
|
|
US5254342A
(en)
|
1991-09-30 |
1993-10-19 |
University Of Southern California |
Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
|
|
DE69311538D1
(de)
|
1992-03-12 |
1997-07-17 |
Alkermes Inc |
Acth enthaltende mikrokugeln mit gesteuerter abgabe
|
|
US5534496A
(en)
|
1992-07-07 |
1996-07-09 |
University Of Southern California |
Methods and compositions to enhance epithelial drug transport
|
|
DE4233152A1
(de)
|
1992-10-02 |
1994-04-07 |
Behringwerke Ag |
Antikörper-Enzym-Konjugate zur Prodrug-Aktivierung
|
|
ES2156149T3
(es)
|
1992-12-04 |
2001-06-16 |
Medical Res Council |
Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
|
|
WO1994016081A1
(de)
|
1993-01-16 |
1994-07-21 |
Manfred Schawaller |
Verfahren zur gewinnung nativer domänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
|
|
WO1994019935A1
(en)
|
1993-03-09 |
1994-09-15 |
Genzyme Corporation |
Isolation of components of interest from milk
|
|
US5514670A
(en)
|
1993-08-13 |
1996-05-07 |
Pharmos Corporation |
Submicron emulsions for delivery of peptides
|
|
NZ273208A
(en)
*
|
1993-09-02 |
2000-12-22 |
Dartmouth College |
Suppressing a humoral immune response against a thymus dependant (TD) antigen
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US6040137A
(en)
|
1995-04-27 |
2000-03-21 |
Tripep Ab |
Antigen/antibody specification exchanger
|
|
US5888773A
(en)
|
1994-08-17 |
1999-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of producing single-chain Fv molecules
|
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US6440418B1
(en)
|
1995-11-07 |
2002-08-27 |
Idec Pharmaceuticals Corporation |
Methods of treating autoimmune diseases with gp39-specific antibodies
|
|
JPH10308991A
(ja)
|
1997-05-07 |
1998-11-17 |
Mitsubishi Electric Corp |
スピーカー取付構造
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
WO1999022008A1
(en)
|
1997-10-27 |
1999-05-06 |
Sumitomo Electric Industries, Ltd. |
Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody
|
|
FR2771640B1
(fr)
|
1997-12-03 |
2000-02-11 |
Inst Nat Sante Rech Med |
Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques
|
|
US6541011B2
(en)
|
1998-02-11 |
2003-04-01 |
Maxygen, Inc. |
Antigen library immunization
|
|
US6051228A
(en)
|
1998-02-19 |
2000-04-18 |
Bristol-Myers Squibb Co. |
Antibodies against human CD40
|
|
PL202844B1
(pl)
|
1998-04-07 |
2009-07-31 |
Corixa Corp |
Immunogeniczny polipeptyd, polinukleotyd, polipeptyd, kompozycja farmaceutyczna, wektor ekspresji, kompozycja szczepionki, polipeptyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis, polinukleotyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis i sposób wytwarzania polipeptydu
|
|
US6573245B1
(en)
|
1998-04-28 |
2003-06-03 |
Galenica Pharmaceuticals, Inc. |
Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
|
|
AU4954899A
(en)
|
1998-06-26 |
2000-01-17 |
Trustees Of Dartmouth College |
Methods and compositions for modulating antigen-specific immunological (humoral)responses by targeting such antigen to apcs in conjunction with anti-cd40 ligan d administration
|
|
US20030118588A1
(en)
*
|
1999-05-22 |
2003-06-26 |
Linda Diehl |
Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40
|
|
US6946129B1
(en)
|
1999-06-08 |
2005-09-20 |
Seattle Genetics, Inc. |
Recombinant anti-CD40 antibody and uses thereof
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
WO2001026608A2
(en)
|
1999-10-14 |
2001-04-19 |
Ledbetter Jeffrey A |
Dna vaccines encoding antigen linked to a domain that binds cd40
|
|
GB9926084D0
(en)
|
1999-11-03 |
2000-01-12 |
King S College London |
Recombinant fusion molecules
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
CA2399790C
(en)
|
2000-02-02 |
2012-10-30 |
Ralph A. Tripp |
Cd40 ligand adjuvant for respiratory syncytial virus
|
|
AU2001259215A1
(en)
|
2000-04-28 |
2001-11-12 |
La Jolla Institute For Allergy And Immunology |
Human anti-cd40 antibodies and methods of making and using same
|
|
US20030059427A1
(en)
|
2000-04-28 |
2003-03-27 |
Force Walker R. |
Isolation and characterization of highly active anti-CD40 antibody
|
|
KR100881471B1
(ko)
|
2000-05-08 |
2009-02-05 |
셀덱스 쎄라퓨틱스, 인크. |
수상세포에 대한 인간 모노클로날 항체
|
|
US7560534B2
(en)
|
2000-05-08 |
2009-07-14 |
Celldex Research Corporation |
Molecular conjugates comprising human monoclonal antibodies to dendritic cells
|
|
US20030232055A1
(en)
|
2000-07-31 |
2003-12-18 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
EP1322383B9
(en)
|
2000-10-02 |
2006-09-06 |
Chiron Corporation |
Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
|
|
US6933123B2
(en)
|
2001-04-05 |
2005-08-23 |
Yao Xiong Hu |
Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
|
|
JP4025881B2
(ja)
|
2001-04-27 |
2007-12-26 |
キリンファーマ株式会社 |
抗ｃｄ４０モノクローナル抗体
|
|
CA2658221C
(en)
|
2001-04-27 |
2012-11-27 |
Kyowa Kirin Co., Ltd. |
Anti-cd40 monoclonal antibody
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
WO2003029462A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
|
WO2003029471A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of apolipoprotein d
|
|
WO2003029296A1
(en)
|
2001-10-02 |
2003-04-10 |
Chiron Corporation |
Human anti-cd40 antibodies
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
US20080199471A1
(en)
|
2002-03-01 |
2008-08-21 |
Bernett Matthew J |
Optimized cd40 antibodies and methods of using the same
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
FR2837104B1
(fr)
|
2002-03-14 |
2004-08-06 |
Dev Des Antigenes Combinatoire |
Utilisation de melange de lipopeptides pour la fabrication de vaccins
|
|
US7456260B2
(en)
|
2002-06-17 |
2008-11-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Humanized antibody
|
|
US8025873B2
(en)
|
2002-06-20 |
2011-09-27 |
Paladin Labs, Inc. |
Chimeric antigens for eliciting an immune response
|
|
US8029803B2
(en)
|
2002-06-20 |
2011-10-04 |
Paladin Labs, Inc. |
Chimeric antigens for eliciting an immune response
|
|
CN100381463C
(zh)
|
2002-09-18 |
2008-04-16 |
中国人民解放军免疫学研究所 |
用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
|
|
US20040146948A1
(en)
|
2002-10-18 |
2004-07-29 |
Centenary Institute Of Cancer Medicine And Cell Biology |
Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments
|
|
MXPA05005051A
(es)
*
|
2002-11-12 |
2006-03-10 |
Albert B Deisseroth |
Vacuna de vector adenoviral.
|
|
JP2004192125A
(ja)
|
2002-12-09 |
2004-07-08 |
Mitsue-Links Co Ltd |
プロジェクトマネジメントシステム及びそれに用いられるデータ構造、並びに、プロジェクトマネジメント方法
|
|
GB0228796D0
(en)
|
2002-12-11 |
2003-01-15 |
Adjuvantix Ltd |
Valency
|
|
EP2230249A3
(en)
|
2003-02-06 |
2010-12-22 |
ChronTech Pharma AB |
Antigen/antibody or ligand/receptor glycosylated specificity exchangers
|
|
ES2531204T3
(es)
|
2003-02-25 |
2015-03-11 |
Vaccibody As |
Anticuerpo modificado
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
US8277810B2
(en)
|
2003-11-04 |
2012-10-02 |
Novartis Vaccines & Diagnostics, Inc. |
Antagonist anti-CD40 antibodies
|
|
CN1922316B
(zh)
|
2003-12-25 |
2011-03-23 |
协和发酵麒麟株式会社 |
抗cd40抗体突变体
|
|
US7892827B2
(en)
|
2004-11-26 |
2011-02-22 |
Pieris Ag |
Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
|
|
EP1877087B1
(en)
|
2005-04-15 |
2013-02-20 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
|
|
US8303955B2
(en)
|
2005-05-26 |
2012-11-06 |
Seattle Genetics, Inc. |
Humanized anti-CD40 antibodies and their methods of use
|
|
JP2007026135A
(ja)
|
2005-07-19 |
2007-02-01 |
Shimizu Corp |
プログラムマネジメントチャート作成支援システム
|
|
CA2620667A1
(en)
|
2005-08-30 |
2007-04-12 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
|
|
CA2623329A1
(en)
|
2005-10-13 |
2007-04-19 |
Virexx Medical Corp. |
Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response
|
|
KR20080074136A
(ko)
|
2005-10-28 |
2008-08-12 |
센토코 인코포레이티드 |
항체의 생성에 있어서의 ｂ 세포 팽창제의 사용
|
|
WO2007103048A2
(en)
|
2006-03-01 |
2007-09-13 |
Regents Of The University Of Colorado |
Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
|
|
USRE46453E1
(en)
*
|
2006-04-19 |
2017-06-27 |
Postech Foundation |
Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
|
|
MX2008013993A
(es)
|
2006-05-03 |
2009-05-11 |
Univ Colorado |
Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
|
|
CA2663222C
(en)
|
2006-09-14 |
2018-01-16 |
Veveo, Inc. |
Methods and systems for dynamically rearranging search results into hierarchically organized concept clusters
|
|
CN103396486A
(zh)
|
2006-10-12 |
2013-11-20 |
中外制药株式会社 |
使用抗ereg抗体的癌症的诊断和治疗
|
|
US20080241139A1
(en)
|
2006-10-31 |
2008-10-02 |
Regents Of The University Of Colorado |
Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity
|
|
CN101657464A
(zh)
|
2007-02-02 |
2010-02-24 |
贝勒研究院 |
与靶向人源化单克隆抗体复合的多变量抗原
|
|
KR20090114430A
(ko)
|
2007-02-02 |
2009-11-03 |
베일러 리서치 인스티튜트 |
항원-제시 세포 상에서 발현된 ｄｃｉｒ에 대한 항원 표적화에 기초한 백신
|
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
|
|
EP2132226B1
(en)
|
2007-02-23 |
2019-03-27 |
Baylor Research Institute |
Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1)
|
|
NZ595319A
(en)
|
2007-02-23 |
2012-09-28 |
Baylor Res Inst |
Activation of human antigen-presenting cells through clec-6
|
|
MX2009008926A
(es)
|
2007-02-23 |
2009-09-14 |
Baylor Res Inst |
Aplicaciones terapeuticas de activacion de celulas que presentan antigeno humano por medio de detectina a-1.
|
|
CN101743249B
(zh)
|
2007-05-11 |
2017-08-08 |
阿尔托生物科学有限公司 |
融合分子与il‑15变异体
|
|
US9149517B2
(en)
|
2007-11-02 |
2015-10-06 |
The Johns Hopkins University |
Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection
|
|
JP5233505B2
(ja)
|
2008-03-17 |
2013-07-10 |
株式会社リコー |
共同作業支援装置、共同作業支援システム、共同作業支援方法、プログラムおよび記録媒体
|
|
ES2685823T3
(es)
|
2008-07-16 |
2018-10-11 |
Baylor Research Institute |
Anticuerpos antagonistas anti-CD40
|
|
CA2735421A1
(en)
|
2008-08-29 |
2010-03-04 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Delivery of a cd40 agonist to a tumor draining lymph node of a subject
|
|
DK2406289T3
(en)
|
2009-03-10 |
2017-05-01 |
Baylor Res Inst |
ANTIGEN PRESENTING CELL TARGETED ANTIVIRUS VACCINES
|
|
CN102770457A
(zh)
|
2009-03-10 |
2012-11-07 |
贝勒研究院 |
靶向抗原呈递细胞的疫苗
|
|
AU2010222942B2
(en)
|
2009-03-10 |
2013-01-10 |
Baylor Research Institute |
Anti-CD40 antibodies and uses thereof
|
|
BRPI1011902A2
(pt)
|
2009-04-28 |
2019-09-24 |
Univ Johns Hopkins |
composições e métodos para potencialização de respostas imunes antígeno-específicas
|
|
ES2898683T3
(es)
|
2009-08-27 |
2022-03-08 |
Novo Nordisk As |
Direccionamiento del factor tisular a las plaquetas activadas
|
|
EP2477655A4
(en)
|
2009-09-14 |
2014-02-12 |
Baylor Res Inst |
VACCINES TREATED ON LANGERHANS CELLS
|
|
WO2011070124A2
(en)
|
2009-12-10 |
2011-06-16 |
Fruitful Innovations B.V. |
Improved catalytic process for reacting carbon dioxide with hydrogen
|
|
GB201003293D0
(en)
*
|
2010-02-26 |
2010-04-14 |
Adjuvantix Ltd |
Cancer vaccine
|
|
BR112012028522A2
(pt)
|
2010-05-07 |
2016-07-19 |
Baylor Res Inst |
sensibilização cruzada mediada por imunorreceptores de células dendríticas (dcir) de células t humanas cd8+
|
|
WO2011158019A1
(en)
*
|
2010-06-16 |
2011-12-22 |
Adjuvantix Limited |
Polypeptide vaccine
|
|
KR20130108295A
(ko)
|
2010-08-13 |
2013-10-02 |
베일러 리서치 인스티튜트 |
항원-제시 세포에 항체에 대한 보조제를 직접 표적화함을 기초로 하는 신규 백신 보조제
|
|
JP5022520B2
(ja)
|
2010-09-01 |
2012-09-12 |
有限会社栄ライト工業所 |
計画作成支援プログラム及び計画作成支援システム
|
|
TW201247706A
(en)
|
2011-03-08 |
2012-12-01 |
Baylor Res Inst |
Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
|
|
US20120244155A1
(en)
|
2011-03-22 |
2012-09-27 |
Baylor Research Institute |
Dendritic Cells (DCs) Targeting for Tuberculosis (TB) Vaccine
|
|
CA2831294A1
(en)
*
|
2011-03-25 |
2012-10-04 |
Baylor Research Institute |
Compositions and methods to immunize against hepatitis c virus
|
|
AR088428A1
(es)
*
|
2011-08-25 |
2014-06-11 |
Baylor Res Inst |
Ensayo multiplexado basado en esferas autoensambladas para anticuerpos especificos de antigenos
|
|
BR112014015016B1
(pt)
|
2011-12-21 |
2023-10-03 |
Nykode Therapeutics ASA |
Proteína homodimérica de duas cadeias de aminoácidos idênticas,cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica,célula hospedeira, método de preparação de uma proteína homodimérica, método de preparação de uma vacina e vacina
|
|
CN120939216A
(zh)
*
|
2014-01-13 |
2025-11-14 |
贝勒研究院 |
抗hpv和hpv相关的疾病的新疫苗
|
|
US9209965B2
(en)
|
2014-01-14 |
2015-12-08 |
Microsemi Semiconductor Ulc |
Network interface with clock recovery module on line card
|